menu search

RLFTF / Relief Therapeutics to Participate in Virtual Investor Conferences in January

Relief Therapeutics to Participate in Virtual Investor Conferences in January
GENEVA, SWITZERLAND / ACCESSWIRE / January 5, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced participation in the following virtual investor conferences in January. - January 10-13: H.C. Read More
Posted: Jan 5 2022, 01:20
Author Name: Accesswire
Views: 111736

RLFTF News  

Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

By Accesswire
September 1, 2023

Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

GENEVA, SWITZERLAND / ACCESSWIRE / September 1, 2023 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief Therapeutics), a bio more_horizontal

Relief Therapeutics to Participate in Virtual Investor Conferences in January

By Accesswire
January 5, 2022

Relief Therapeutics to Participate in Virtual Investor Conferences in January

GENEVA, SWITZERLAND / ACCESSWIRE / January 5, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a biopharmaceutical co more_horizontal

Relief Therapeutics to Participate in Virtual Investor Conferences in January

By Accesswire
January 5, 2022

Relief Therapeutics to Participate in Virtual Investor Conferences in January

GENEVA, SWITZERLAND / ACCESSWIRE / January 5, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a biopharmaceutical co more_horizontal

Relief Therapeutics to Participate in Virtual Investor Conferences in January

By Accesswire
January 5, 2022

Relief Therapeutics to Participate in Virtual Investor Conferences in January

GENEVA, SWITZERLAND / ACCESSWIRE / January 5, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a biopharmaceutical co more_horizontal

Relief Therapeutics Announces Filing of Lawsuit Against its U.S. Collaboration Partner, NeuroRx, Inc. and its CEO, Dr. Jonathan Javitt, for RLF-100(TM) (Aviptadil)

By Accesswire
October 6, 2021

Relief Therapeutics Announces Filing of Lawsuit Against its U.S. Collaboration Partner, NeuroRx, Inc. and its CEO, Dr. Jonathan Javitt, for RLF-100(TM) (Aviptadil)

Lawsuit alleges multiple breaches of Collaboration Agreement GENEVA, SWITZERLAND / ACCESSWIRE / October 7, 2021 / RELIEF THERAPEUTICS Holding SA (SIX: more_horizontal

Relief Therapeutics Announces Filing of Lawsuit Against its U.S. Collaboration Partner, NeuroRx, Inc. and its CEO, Dr. Jonathan Javitt, for RLF-100(TM) (Aviptadil)

By Accesswire
October 6, 2021

Relief Therapeutics Announces Filing of Lawsuit Against its U.S. Collaboration Partner, NeuroRx, Inc. and its CEO, Dr. Jonathan Javitt, for RLF-100(TM) (Aviptadil)

Lawsuit alleges multiple breaches of Collaboration Agreement GENEVA, SWITZERLAND / ACCESSWIRE / October 7, 2021 / RELIEF THERAPEUTICS Holding SA (SIX: more_horizontal

Relief Therapeutics Announces Filing of Lawsuit Against its U.S. Collaboration Partner, NeuroRx, Inc. and its CEO, Dr. Jonathan Javitt, for RLF-100(TM) (Aviptadil)

By Accesswire
October 6, 2021

Relief Therapeutics Announces Filing of Lawsuit Against its U.S. Collaboration Partner, NeuroRx, Inc. and its CEO, Dr. Jonathan Javitt, for RLF-100(TM) (Aviptadil)

Lawsuit alleges multiple breaches of Collaboration Agreement GENEVA, SWITZERLAND / ACCESSWIRE / October 7, 2021 / RELIEF THERAPEUTICS Holding SA (SIX: more_horizontal


Search within

Pages Search Results: